Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
105.9 USD | -0.00% | -1.58% | -3.85% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.85% | 184B | |
-0.74% | 107B | |
-3.02% | 69.44B | |
+3.72% | 50.37B | |
+8.37% | 44.82B | |
+3.40% | 41.53B | |
+3.03% | 26.84B | |
+3.45% | 26.73B | |
+15.23% | 25.71B | |
-0.80% | 24.34B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Morningstar Upgrades Abbott Laboratories to Buy From Hold, $104 Price Target